Back

Trends in opioid seizure data and their association with opioid mortality

McBrien, H.; Alexander, M.

2022-10-11 addiction medicine
10.1101/2022.10.08.22280845
Show abstract

BackgroundThe opioid epidemic remains an emergent health issue in the United States, as opioid-related deaths continue to rise in the second year of COVID-19. The introduction of synthetic opioids into the illicit supply began causing deaths in 2015, however, data describing the illicit opioid supply is scarce. MethodsWe used a newly available national dataset of drug seizure reports, aggregated from law enforcement agencies across the United States, to describe changes in fentanyl, heroin, and other opioid presence in the national illicit supply from 2011-2017, by state and geographic region. We assessed the relationship between drug seizures and opioid-related deaths at the state level using linear regression. ResultsNational and state increases in opioid seizure rates from 2011-2017 were entirely due to increased fentanyl and heroin seizures, as other opioid seizure rates remained constant. Most increases in seizures occurred in the Northeast, Midwest, and Appalachia, where fentanyl seizures and heroin seizures were highest and increased most sharply along with opioid deaths. The composition of drugs seized was similar within geographic regions, but did vary across regions. State opioid seizures of all types were strongly associated with state opioid deaths. The strongest relationship was between fentanyl seizures and fentanyl deaths. ConclusionsThe association between opioid seizures and deaths means seizure data has potential as an early-warning system to predict overdose, although national level data requires quality improvement. Regional variation in seizure rates supports existing evidence that illicit fentanyl and heroin supplies differ between regions, producing distinct regional risk environments, causing varying mortality rates.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
International Journal of Drug Policy
based on 11 papers
Top 0.1%
18.4%
2
Drug and Alcohol Dependence
based on 21 papers
Top 0.2%
14.4%
3
JAMA Network Open
based on 125 papers
Top 1%
8.2%
4
Addiction
based on 24 papers
Top 0.6%
6.9%
5
Neuropsychopharmacology
based on 29 papers
Top 0.3%
6.9%
50% of probability mass above
6
PLOS ONE
based on 1737 papers
Top 65%
5.8%
7
Scientific Reports
based on 701 papers
Top 38%
4.9%
8
Pharmacoepidemiology and Drug Safety
based on 12 papers
Top 0.2%
3.0%
9
Frontiers in Psychiatry
based on 56 papers
Top 3%
3.0%
10
Addiction Biology
based on 13 papers
Top 0.4%
3.0%
11
Brain Stimulation
based on 27 papers
Top 1%
2.6%
12
Translational Psychiatry
based on 94 papers
Top 5%
2.5%
13
American Journal of Psychiatry
based on 14 papers
Top 0.6%
1.7%
14
The Lancet Public Health
based on 20 papers
Top 0.4%
1.7%
15
Journal of General Internal Medicine
based on 19 papers
Top 3%
0.9%
16
Biological Psychiatry
based on 36 papers
Top 4%
0.9%
17
JMIR Public Health and Surveillance
based on 45 papers
Top 10%
0.9%
18
PeerJ
based on 46 papers
Top 9%
0.9%
19
npj Digital Medicine
based on 85 papers
Top 12%
0.9%
20
JAMA Psychiatry
based on 11 papers
Top 0.9%
0.9%
21
International Journal of Environmental Research and Public Health
based on 116 papers
Top 20%
0.9%
22
The Lancet Regional Health - Americas
based on 20 papers
Top 0.7%
0.9%
23
Frontiers in Artificial Intelligence
based on 11 papers
Top 2%
0.7%
24
The British Journal of Psychiatry
based on 21 papers
Top 4%
0.7%